Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism

NCT02944110 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Diabetes After Total Pancreatectomy

Interventions

DRUG: Glucagon receptor antagonist LY2409021
DRUG: Placebo

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]